We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
+3.58%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$251M
AUM Growth
+$17.5M
(+7.5%)
Cap. Flow
+$12.1M
Cap. Flow
% of AUM
4.81%
Top 10 Holdings %
Top 10 Hldgs %
73.45%
Holding
118
New
10
Increased
17
Reduced
7
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$8.13M |
| 2 |
FTAI Aviation
FTAI
|
+$4.74M |
| 3 |
Upland Software
UPLD
|
+$3.95M |
| 4 |
Viking Therapeutics
VKTX
|
+$674K |
| 5 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
+$476K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$4.88M |
| 2 |
Pfizer
PFE
|
+$1.63M |
| 3 |
ATCO
Atlas Corp.
ATCO
|
+$993K |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$752K |
| 5 |
SHPG
Shire pic
SHPG
|
+$460K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 64.84% |
| 2 | Financials | 7.67% |
| 3 | Technology | 5.84% |
| 4 | Energy | 5.67% |
| 5 | Industrials | 4.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Alerian MLP ETF
AMLP
$13.4B
| $6K | ﹤0.01% |
120
| – | – |
|
|
SCU
102
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $5K | ﹤0.01% |
200
| – | – |
|
103
The RMR Group
RMR
$332M
| $1K | ﹤0.01% |
16
| – | – |
|
104
Acadia Pharmaceuticals
ACAD
$5.02B
| – | – |
-550
| Closed | -$21K |
|
105
General Mills
GIS
$22.2B
| – | – |
-5,000
| Closed | -$202K |
|
|
ATCO
106
DELISTED
Atlas Corp.
ATCO
| – | – |
-140,000
| Closed | -$993K |
|
|
REED
107
DELISTED
Reeds, Inc. Common Stock
REED
| – | – |
-2,352
| Closed | -$259K |
|
|
GBT
108
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
-24,224
| Closed | -$752K |
|
|
ARRY
109
DELISTED
Array Biopharma Inc
ARRY
| – | – |
-6,900
| Closed | -$85K |
|
|
OCRX
110
DELISTED
Ocera Therapeutics, Inc.
OCRX
| – | – |
-39,800
| Closed | -$45K |
|
|
PKY
111
DELISTED
Parkway, Inc.
PKY
| – | – |
-1,678
| Closed | -$39K |
|
|
SHPG
112
DELISTED
Shire pic
SHPG
| – | – |
-3,003
| Closed | -$460K |
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q4 2017 Portfolio in Review
As of Q4 2017, David M. Knott held 118 positions worth $251M, up 7.5% from $234M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
David M. Knott deployed $12.1M of net new capital in Q4 2017, opening 10 new positions and adding to 17 existing holdings. Its largest new stake was FTAI Aviation: 302,001 shares worth $5.14M.
By sector, the portfolio is most concentrated in Healthcare at 65% of assets, down from 71% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Ligand Pharmaceuticals, an estimated $4.88M trimmed.
- David M. Knott's largest Q4 2017 buy was FTAI Aviation: 302,001 shares worth $5.14M.
- David M. Knott added most to Macquarie Infrastructure Holdings, LLC in Q4 2017, an estimated $8.13M increase.
- David M. Knott's biggest Q4 2017 reduction was Ligand Pharmaceuticals, cutting an estimated $4.88M.
- David M. Knott fully exited Atlas Corp. in Q4 2017, selling an estimated $993K.
- David M. Knott's ten largest holdings make up 73% of its $251M portfolio in Q4 2017.
- David M. Knott opened 10 new positions and closed 9 in Q4 2017.
- David M. Knott's portfolio value rose 7.5% quarter-over-quarter to $251M.
Based on David M. Knott's 13F filing for Q4 2017, filed 13 Feb 2018.